Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Woodcock Outlines Priorities For Next US FDA Commissioner

Dec 13 2021

• By Derrick Gingery

Priority compass — • Source: Alamy

Related Content

US FDA’s Human Drugs Program Suffers In Adjustment Of Agency Priorities

Feb 11 2020

From EUA To Full Approval: CDER, CBER Still Developing Transition Plans

Oct 15 2020

With Pfizer EUA For 5-11 And Moderna Delay For Adolescents, US FDA Walks Myocarditis Tightrope

Nov 01 2021

Janssen Gets US FDA Panel Nod For Additional COVID Vaccine Shot – But Is It A ‘Booster’?

Oct 16 2021

CBER Proposes Increasing Cell, Gene Therapy Staff In PDUFA VII

Jan 07 2021

Pandemic Perspectives: US FDA ACTT’s On Its Faith In Randomized Trials With Veklury Approval Despite WHO Study

Mar 16 2021

Pfizer’s Comirnaty: Emerging Myocarditis Signal Drew Flurry Of Attention During Compressed BLA Review

Nov 26 2021

Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite Lightly

Nov 12 2021

Holding ANDA Labeling Review Until Late Cycle Could Minimize Delays From Last-Minute Changes

Dec 08 2021

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Janssen Biotech Inc.

Gilead Sciences, Inc.

Additional Topics

International United States US States Consumer FDA Leadership Commercial Compliance Enforcement Policy Politics Regulation

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window